Condition
Terminal Liver Disease
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Htkplacebo
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Phase 2/3 (1)
Trial Status
Terminated1
Clinical Trials (1)
Research Network
Common Treatments
- Htkplacebo1
- Tacrolimus1
Active Sponsors
- Ludwig-Maximilians - University of Munich1
Top Investigators
Ludwig-Maximilians-University, Department of Surgery, Munich, Germany
Ludwig-Maximilians-University, Department of Surgery, Munich, Germany
Ludwig-Maximilians-University, Department of Surgery, Munich, Germany
Related Conditions
- Poor Graft Quality1
- Ischemia Reperfusion Injury1
- Graft Failure1
- Graft Dysfunction1